How Does the Market View Stryker?

After this afternoon's 3.2% surge to $300.2 per share, Stryker might just keep moving past its target price of $289.74. With an average analyst rating of buy, and target prices from $250.0 to $326.0, the stock's next move is anyone's guess.

Stryker's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.9%. The stock's short ratio is 5.44. The company's insiders own 6.48% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 80.2%. In conclusion, we believe there is positive market sentiment regarding Stryker.

Institutions Invested in Stryker

Date Reported Holder Percentage Shares Value
2022-12-31 Vanguard Group, Inc. (The) 8% 30,246,178 $9,080,053,460
2022-12-31 Blackrock Inc. 6% 24,495,068 $7,353,541,560
2022-12-31 Greenleaf Trust 5% 19,635,485 $5,894,670,510
2022-12-31 Wellington Management Group, LLP 4% 17,030,078 $5,112,514,337
2022-12-31 Price (T.Rowe) Associates Inc 4% 14,964,141 $4,492,309,747
2022-12-31 State Street Corporation 4% 14,119,016 $4,238,599,008
2022-12-31 Capital Research Global Investors 4% 14,076,626 $4,225,873,319
2022-12-31 Bank Of New York Mellon Corporation 2% 6,584,506 $1,976,701,535
2022-12-31 Morgan Stanley 2% 5,978,782 $1,794,860,170
2022-12-31 Geode Capital Management, LLC 2% 5,836,252 $1,752,071,953
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.